mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.0072 |
0.8 |